Challenges in Obtaining Informed Consent in Qualitative Research and Suggestions to Improve It- A Descriptive Qualitative Study

Challenges in Obtaining Informed Consent in Qualitative Research and Suggestions to Improve It- A Descriptive Qualitative Study
National Journal of Community Medicine, June 2023; 14(06) pp 386-390
Sindhuri, Amol Dongre
Abstract
Introduction
The dynamic and flexible nature of qualitative studies is expected to impose new challenges upon the researchers in obtaining informed consent. The study objectives were to explore the challenges perceived by the researchers in obtaining informed consent in qualitative research and their suggestions to improve it.
Material and Methods
It was a descriptive qualitative study in which In-depth interviews were conducted among ten qualitative researchers purposively selected from one medical college in Puducherry. Transcripts prepared from the audio recordings were thematically analyzed manually.
Results
The challenges identified were inadequate knowledge of the researcher in designing qualitative consent form, reluctance to sign consent document by participant, ensuring confidentiality and risk benefit communication. The main suggestions provided by the participants were to use of multimedia tools to improve their understanding and creating a rapport to enhance their trust to participate in the study.
Conclusions
Since most of the challenges were related to the reluctance of participants to provide consent due to various reasons and lack of adequate knowledge of the researcher, creating a good rapport with the participants and providing simple information through multimedia approaches and ethical training of qualitative researchers will aid us to overcome majority of these challenges.

‘It’s All Public Anyway’: A Collaborative Navigation of Anonymity and Informed Consent in a Study with Identifiable Parent Carers

‘It’s All Public Anyway’: A Collaborative Navigation of Anonymity and Informed Consent in a Study with Identifiable Parent Carers
Pam Joseph
Ethics and Social Welfare, 30 May 2023
Abstract
For qualitative researchers seeking the perspectives of people with unusual characteristics or circumstances, compliance with expectations about participant anonymity can be difficult, if not impossible. In the age of internet communications and emerging research methodologies, traditional strategies require ongoing re-examination to ensure cohesion between a project’s ethical framework and its research practice. This paper reflects on the approach to informed consent used in a study with parent carers whose children had high-level support needs. A two-step process of written consent was developed in response to concerns about the possible re-identification of these parents as a result of their highly individual circumstances. This approach acknowledged the potential for identification, and maximised participants’ agency in choosing the level of risk that they were comfortable to accommodate. The paper discusses the researcher’s and participants’ responses to the adapted consent process and recommends that researchers and ethics review committees remain open to the development of collaborative and innovative approaches that are also culturally and contextually relevant, to enable people to contribute perspectives that might otherwise be silenced by the very ethical frameworks that purport to protect their interests.

Get this thing out of my body! Factors determining consent for translational oncology research: a qualitative research

Get this thing out of my body! Factors determining consent for translational oncology research: a qualitative research
Research
Desprès Caroline, Mamzer Marie-France
Journal of Translational Medicine volume, 21 May 2023; 21(336)
Open Access
Abstract
Background
Depending on the needs of scientific research at a given time, biobanks make biological samples and data available to researchers. In this article, we aim to describe the reasons and underlying logic that determine the decision to grant or deny consent to the conservation of tumour samples in a biological resource platform for research purposes. We make use of the CARPEM biological resource platform model, where broad consent is required.
Methods
The results are based on semi-structured interviews, conducted between 2019 and 2021, with 25 individuals having various profiles.
Results
All the people interviewed readily accepted the principle of conserving a tumour sample for research purposes. They explained their decision by citing the desire to participate in research dedicated to improving therapeutic medicine. Their trust in research institutions or in doctors was an important factor in their consent. The tumorous nature of the samples also played an important role, as did the absence of constraints. Finally, the high level of consent was also based on the difficulty they had in conceiving what the future risks might be once the sample had been taken, whereas the fact that they did not know the nature or purpose of the research to be carried out when they signed the consent form posed some problems. These results stem from a lack of a culture of ethics among the people interviewed.
Conclusion
The information provided in the context of consent at the CARPEM tumour bank seems inadequate for consent to be considered ‘informed’, given the low level of knowledge that people have of the risks and issues. Information is missing even though we feel it would not change consent or only marginally. This raises questions, since part of the act of granting consent is based on the implicit trust French people have in the hospital that collects the data and in research practices in general. In the minds of those who participate, transparency is the ground on which trust rests. Lack of transparency could be deleterious for future research practices. However, it is not by striving to improve information leaflets that the consent-related information will improve but, rather, by more effectively helping future patients to assimilate that information.

COVID-19 Vaccination and the Role of Informed Consent: England as a Case Study

COVID-19 Vaccination and the Role of Informed Consent: England as a Case Study
Caterina Milo
European Journal of Health Law, 22 May 2023
Abstract
Informed consent (IC), following the Supreme Court judgment in Montgomery v Lanarkshire Health Board, [2015] UKSC 11, constitutes a key patients’ right. There is a vast literature exploring the significance of this right, while an analysis of the role that this has played in England during the COVID-19 vaccine distribution has been under-explored. Using England as a case study, this paper argues that IC has received limited protection in the COVID-19 vaccination context of the adult population, upholding at its best only a minimalistic approach where mere ‘consent’ has been safeguarded. It suggests that new approaches should be brainstormed so as to more properly safeguard IC in a Montgomery-compliant-approach, namely in a way that enhances patients’ autonomy and medical partnership, and also to better prepare and respond to future pandemics.

Psychedelic treatments for mental health conditions pose challenges for informed consent

Psychedelic treatments for mental health conditions pose challenges for informed consent
Comment
Carolina Seybert, Gonçalo Cotovio, Luís Madeira, Miguel Ricou, Ana Matos Pires, Albino J. Oliveira-Maia
Nature Medicine, 14 June 2023
Excerpt
   Enhanced informed consent procedures are needed for patients treated with psychedelics such as psilocybin and MDMA, due to effects that include an altered state of consciousness and vulnerability to suggestion.

In past years, clinical trials with psychedelic substances have been conducted to find alternative treatments for hard-to-treat mental health conditions such as treatment-resistant depression1, cancer-related depression and anxiety symptoms2 and post-traumatic stress disorder3. Clinical research has advanced under the regulation of national ethical and medication authorities for clinical trials, much as for any study testing a new intervention. Indeed, recent research on psychedelics has been conducted under the protected conditions of clinical trials, following international guidelines. However, psychedelic treatments present unique ethical and regulatory challenges that may not have been fully addressed within the traditional structures of clinical trial regulation4. These challenges need to be addressed before these substances are approved for use in general clinical practice…

Informed consent and compulsory treatment on individuals with severe eating disorders. A bio-ethical and juridical problem

Informed consent and compulsory treatment on individuals with severe eating disorders. A bio-ethical and juridical problem
M. Damato, P. Ricci, R. Rinaldi
Clinica Terapeutica, 2023; 174(4) pp 211-215
Abstract
Background
The problem concerning the activation of the measure of Compulsory Health Treatment (CHT) for subjects suffering from Eating Disorders (ED) represents a legal paradox that places health professionals in the position of frequently doubting the real usefulness of the measure within the hospital context. This issue is mainly related to anorexia nervosa, which puts the subject in a higher life-threatening situation than other EDs.
Method and materials
To outline the current state of the art, the most recent national and international scientific publications concerning informed consent and CHT in EDs were searched. In addition, Italian rulings in various degrees of judgement were evaluated with the suggestion of a possible resolution of these issues.
Results
The analysis of the literature showed that although a multitude of psychometric instruments has been created to identify the ability to give informed consent, there are still not all the elements necessary to identify the actual degree of disease awareness of ED subjects. An important factor could be the exploration of the person’s interception, which has been seen to be very high in individuals with AN who are known not to experience the sensation of hunger. At present, reviews of the bibliography and judgments have shown that the measurement of CHT remains crucial if it is intended as a lifesaving treatment. However, it is evident that in terms of BMI, CHT is not a definitive intervention and therefore the adoption of this practice is necessary with extreme caution taking into account the person’s actual ability to consent.
Conclusions
Future studies will have the task of determining the psychic factors necessary to better understand the state of the person in his or her physical and mental wholeness, giving due weight to these characteristics and orienting knowledge in a practical sense to more profitable direct treatment for individuals with ED.

Editor’s note: This is an Italian language publication.

Withdrawal of consent for processing personal data in biomedical research

Withdrawal of consent for processing personal data in biomedical research
Marcu Florea
International Data Privacy Law, 15 June 2023
Open Access
Excerpt
In the context of biomedical research, consent is both a ground for the lawful processing of personal data and a bioethical requirement for participation in scientific research projects. While the conditions for obtaining valid consent are extensively discussed in legal and bioethical literature, withdrawal of consent has received considerably less attention. According to the EU General Data Protection Regulation (GDPR), that data subjects have the right to withdraw their consent at any time, but the duties of the entities processing personal data are not clearly defined in the text of the Regulation. Pursuant to Article 7 GDPR, withdrawal ‘shall not affect the lawfulness of processing based on consent before its withdrawal’, but there is no clear specification of the rules governing what happens after this moment…

Obtaining Informed Consent for Future Reuse of Patient Data

Obtaining Informed Consent for Future Reuse of Patient Data
Kelly FitzGerald
Applied Clinical Trials, 8 June 2023; 32(6)
Excerpt
…One of the first national policies regarding this was the National Institutes of Health (NIH) Genomic Data Sharing Policy enacted in 2014, which established the expectation of broad and responsible sharing of genomic research data. During the public comment period and subsequent publication of the final policy, the issue of adequate informed consent for this kind of far-reaching research was raised. This resulted in NIH recommending that investigators seek the broadest consent possible when first obtaining consent from participants. However, NIH recognized that in some cases, limits will still be required, and it allows for use of controlled access databases as a way to mitigate concerns.

The policy requires that participants provide consent for sharing their data, even after it is de-identified, in order for the data to be deposited in an accessible database. The policy also requires that institutions, usually by way of their institutional review boards (IRBs), confirm the data sharing is consistent with the informed consent of study participants, and that consideration was given to the risks to individual participants and their families as well as groups or populations associated with the data…

Massive Omission of Consent (MOOC): Ethical Research in Educational Big Data Studies

Massive Omission of Consent (MOOC): Ethical Research in Educational Big Data Studies
Eamon Costello, James Brunton, Richard Bolger, Tiziana Soverino, Clément Juillerac
Online Learning Journal, 1 June 2023
Abstract
Ethical reviews of research plans function as a cornerstone of good research practice in order that no harm should come to participants. Ethical concerns have taken on a new salience in a digital world where data can be generated at scale. Big data research has grown rapidly, raising increased ethical concerns. Several intersecting areas of big data research exist within educational research, such as learning analytics, artificial intelligence (AI), and Massive Open Online Courses (MOOCs). In the current study, an investigation was made of peer-reviewed papers on MOOC teaching and learning to determine if they explicitly refer to (a) ethical considerations in their studies, and (b) obtaining formal ethical approval for their research. This investigation was accomplished through a review of MOOC-related, English-language papers available in Scopus database, over the course of a year. The review produced a total of 1,249 articles, of which, 826 articles related to empirical studies involving human participants where full text of the articles could be obtained. The string “ethic” was searched for within these articles, and resulting articles analyzed, which found that a small fraction, 42 articles (5.08%), mention ethics in relation to the study presented in the article, and only 13 articles (1.57%) explicitly mention obtaining formal ethical approval for the research. The findings show a lack of transparency in reporting on and/or engagement with ethical considerations in MOOC teaching and learning research. These findings indicate the need for further stakeholder engagement and sectoral dialogue in relation to ethics education and training for researchers; consideration of ethics in big data studies in education; and norms/policies in academic publishing for authors to report how ethical issues have been considered.

Consent, assent and randomised evaluations

Consent, assent and randomised evaluations
Discussion
Michael Sanders, Jack Summers, Vanessa Hirneis, Susannah Hume, Gabrielle McGannon
Policy Press, 9 June 2023
Abstract
Background
Randomised trials have been on the rise in social policy over the last decade and a half, particularly in areas working with young people and vulnerable adults. Informed consent is an important principle for ethics committees governing research conducted by universities.
Aims and objectives
We consider the arguments for and against opt-in consent by parents, and opt-out assent, when it comes to trials taking place, particularly in schools.
Methods
We review what is known about this from a methodological standpoint.
Findings
We find that extant evidence suggests that requiring opt-in consent, rather than assent, to participation, risks reducing the ethical standards of trials by minimising participation; and by potentially risking disclosure of sensitive information about a child’s life to their parents. Moreover, there are important equity considerations, with more vulnerable groups likely to be excluded from research findings under an opt-in framework.
Discussion and conclusion
We conclude that the ethical argument for assent rather than consent is compelling under some circumstances, and should be considered on a case-by-case basis. Precautions must always be taken to safeguard participants.

Editor’s note: Policy Press is a product of Bristol University.